Document is current

Any future updates will be listed below

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

Crossref DOI link: https://doi.org/10.1186/s12885-017-3131-x

Published Online: 2017-02-15

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark